Injectable Drug Delivery: The Essential Annual Conference for Pharmaceutical and Medical Device Professionals in the Parenteral Drug Delivery Industry (London, United Kingdom - March 22-23, 2018)

Agenda:

Programme - Day one

Chairman's welcome and introduction

Dr Greg Berman, Independent Consultant, UK

Trends in Injection Devices

Mark Chipperfield, Company Director and Principal Consultant, Corvus Device, UK

Latest devices - connectivity with injectables

Markus Bauss, Managing Director, SHL Group, Germany

Ypsomed delivery systems for large volume self-injection and connectivity

Ian Thompson, Vice President Business Development, Ypsomed

Connected health - getting to market with an electronic auto-injector, app and cloud services

Neil Williams, Director, Front-End Innovation, Head of Connected Health, Medicom Innovation Partner, UK

Pre-filled syringes over time

Andreas Rothmund, Qualified Person, Vetter Pharma-Fertigung GmbH & Co KG Germany

Using polymeric PDC technology to improve auto-injector design

Jonathan Bradshaw, Device Development Engineer, Oval Medical Technologies, UK

Polymers for better injection devices

Ian Wands, Market Development Specialist, DuPont Performance Materials, UK

Large volume injectors: one device - multiple solutions

Mike Hooven, CEO, Enable Injections, USA

Networking drinks reception

Programme - Day two

Review of day one

Dr Greg Berman, Independent Consultant, UK

What do pharma companies want from devices?

Dr David Jefferys, Senior Vice President Global Regulatory, Government Relations and European Product Safety, Eisai Europe Ltd, UK

The EU regulatory framework for injectable delivery systems

Stephen Dew, Associate Director RA (CMC) Combination Products, Biogen, UK

US regulatory considerations for injectable delivery systems

Suzette Roan, Senior Director, Global Regulatory Affairs, Sanofi, USA

Advances in Needle Free Drug Delivery

Andrew Coats, Director of Engineering, Portal Instruments, USA

Enhance existing devices or move to brand new integrated solutions? Two approaches for smart pen injectors

Arnaud Guillet, Business Development Associate, Bicorp, France

Human factors in injectable drug delivery

Greg Thay, Human Factors Director, Medical Devices,Thay Medical, UK

Key training device considerations for injection based therapies

Joe Reynolds, Research Manager at Noble, UK

For more information about this conference visit https://www.researchandmarkets.com/research/2l9rzs/injectable_drug?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716